Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Fuji
Federal Trade Commission
QuintilesIMS
Accenture
US Army
Cantor Fitzgerald
Cerilliant
Dow

Generated: June 25, 2018

DrugPatentWatch Database Preview

ANTRENYL Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Antrenyl patents expire, and what generic alternatives are available?

Antrenyl is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in ANTRENYL is oxyphenonium bromide. Additional details are available on the oxyphenonium bromide profile page.
Summary for ANTRENYL
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 27
Patent Applications: 274
DailyMed Link:ANTRENYL at DailyMed
Drug patent expirations by year for ANTRENYL
Medical Subject Heading (MeSH) Categories for ANTRENYL
Synonyms for ANTRENYL
{2-[(2-cyclohexyl-2-hydroxy-2-phenylacetyl)oxy]ethyl}diethylmethylazanium bromide
14214-84-7 (Parent)
2-([Cyclohexylhydroxyphenylacetyl]oxy)-N,N-diethyl-N-methylethanaminium bromide
2-(2-cyclohexyl-2-hydroxy-2-phenylacetoxy)-N,N-diethyl-N-methylethan-1-aminium bromide
2-(2-cyclohexyl-2-hydroxy-2-phenylacetyl)oxyethyl-diethyl-methylazanium bromide
2-(2-cyclohexyl-2-hydroxy-2-phenylacetyl)oxyethyl-diethyl-methylazanium;bromide
2-[(Cyclohexylhydroxyphenyl- acetyl)oxy]-N,N-diethyl-N- ethylethanaminium bromide
2-[(Cyclohexylhydroxyphenyl-acetyl)oxy]-N,N-diethyl-N-ethylethanaminium bromide
50-10-2
AC1L1L1T
AC1Q1RI8
ACM50102
AKOS030507607
Ammonium, diethyl(2-hydroxyethyl)methyl-, bromide, alpha-phenylcyclohexaneglycolate
Antrenyl (TN)
Antrenyl bromide
API0003724
BA-5473
Bromure d'oxyphenonium
Bromure d'oxyphenonium [INN-French]
Bromuro de oxifenonio
Bromuro de oxifenonio [INN-Spanish]
C 5473
C21H34BrNO3
C21H34NO3
CAS-50-10-2
CCG-101094
CCG-213986
CHEMBL1200906
CPD000058660
CTK8G2234
D06877
Diethyl(2-hydroxyethyl)methylammonium bromide alpha-phenylcyclohexaneglycolate
diethylaminoethyl a-phenylcyclohexaneglycolate methylbromide
DSSTox_CID_25632
DSSTox_GSID_45632
DSSTox_RID_81014
DTXSID4045632
EINECS 200-010-7
Ethanaminium, 2-((cyclohexylhydroxyphenylacetyl)oxy)-N,N-diethyl-N-methyl-, bromide
Ethanaminium, 2-((cyclohexylhydroxyphenylacetyl)oxy)-N,N-diethyl-N-methyl-, bromide (9CI)
HMS2052O07
HMS2230J18
HMS3371M04
HMS3394O07
LS-17433
MCULE-1491988845
METHACIN BROMIDE
MFCD00050259
MLS000028620
MLS001076268
MLS001424168
MolPort-000-735-345
NC00344
NCGC00018256-02
NCGC00018256-06
NSC-759248
NSC759248
Opera_ID_1635
OR073143
OR219605
Oxifenon
Oxyfenon
Oxyphenon
Oxyphenonii bromidum
Oxyphenonii bromidum [INN-Latin]
OXYPHENONIUM BROMIDE
Oxyphenonium bromide (INN)
Oxyphenonium bromide [INN:BAN]
Oxyphenoniumbromide
Pharmakon1600-01505783
REGID_for_CID_5748
SAM001246887
SCHEMBL248890
SMR000058660
Spasmophen
spasmophen bromide
Subranyl
Tox21_110851
Tox21_110851_1
V0895
Z1551429731

US Patents and Regulatory Information for ANTRENYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis ANTRENYL oxyphenonium bromide TABLET;ORAL 008492-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Covington
Fish and Richardson
Colorcon
McKinsey
Moodys
Boehringer Ingelheim
Citi
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.